Duchenne Muscular Dystrophy Clinical Trials in Norfolk, Virginia

3 studies are recruiting for duchenne muscular dystrophy in Norfolk, Virginia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

    Cohort 8 (non-ambulatory participants) is currently enrolling new participants. Enrollment for Cohorts 1 through 7 has been completed. This is an open-label gene transfer therapy study evaluating the safety of and expression from delandistrogene moxeparvovec in participants with Duchenne Muscular D…

    Stage
    Phase 1
    Ages
    2 and older
    Site
    Children's Hospital of The King's Daughters, Norfolk, Virginia
    Locations
    12 in total
    Run by
    Sarepta Therapeutics, Inc.

    See if you can join NCT04626674 on ClinicalTrials.gov

  2. A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

    This is a Phase 3, double-blind, placebo-controlled study with the primary objective of evaluating the efficacy of a single IV infusion of SGT-003 in pediatric ambulant male participants with DMD. The secondary objectives include the evaluation of additional efficacy and safety outcomes. The study …

    Stage
    Phase 3
    Ages
    7 to 11
    Site
    Children's Hospital of the King's Daughters, Norfolk, Virginia
    Locations
    7 in total
    Run by
    Solid Biosciences Inc.

    See if you can join NCT07160634 on ClinicalTrials.gov

  3. A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

    This is a multicenter, open-label, non-randomized study to investigate the safety, tolerability, and efficacy of a single intravenous (IV) infusion of SGT-003 in participants with Duchenne muscular dystrophy. There will be 5 cohorts in this study. Cohort 1 will include participants 4 to < 7 years o…

    Stage
    Phase 1
    Ages
    0 to 17
    Site
    Children's Hospital of the King's Daughters, Norfolk, Virginia
    Locations
    15 in total
    Run by
    Solid Biosciences Inc.

    See if you can join NCT06138639 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.